Home LiteratureArticle Details
PMID: 2494117 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Inhibition by normal human serum of Mycobacterium avium multiplication in cultured human macrophages.

Infection and immunity ·Vol. 57 ·No. 4 ·1989-04-00 ·Pages 1332-5

Crowle AJ, Poche P

Abstract

Normal human serum used as a protein supplement in RPMI 1640 medium inhibited growth in blood-derived human macrophages (MP) of virulent Mycobacterium avium serovars 4 and 8, derived from patients with acquired immunodeficiency syndrome, but not virulent Mycobacterium tuberculosis. A defined serum substitute (SS) promoted the intramacrophage growth of M. avium but not of M. tuberculosis. The effects of serum or SS were measured by counting viable bacteria in lysates of the MP at 0, 4, and 7 days after their infection by the bacteria. Neither serum nor SS inhibited or enhanced M. avium growth in the absence of MP. The results suggest that a nutrient essential for intracellular replication of M. avium is made by MP from a pronutrient present in both SS and serum and that something in serum inhibits MP conversion of the pronutrient to nutrient. This inhibition may be an important mechanism of native resistance against M. avium in normal people.

MeSH Terms
Acquired Immunodeficiency Syndrome/microbiology Adult Blood Bactericidal Activity Cells, Cultured Humans Macrophages/immunology,microbiology Middle Aged Mycobacterium avium/growth & development,immunology Mycobacterium tuberculosis/growth & development,immunology
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Crowle A J
Webb-Waring Lung Institute, Department of Microbiology and Immunology, Denver, Colorado 80262.
Poche P
References (9)
9 references, click to expand
  1. Factors that affect the cell cycle of Mycobacterium avium.
    Rev Infect Dis. 1981 Sep-Oct;3(5):914-25 PMID: 7339822
  2. Characterization of biological response modifier release by human monocytes cultured in suspension in serum-free medium.
    J Immunol Methods. 1984 May 25;70(2):245-55 PMID: 6202795
  3. Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages.
    J Clin Microbiol. 1986 Nov;24(5):812-21 PMID: 3771767
  4. Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages.
    Infect Immun. 1987 Dec;55(12):2945-50 PMID: 3119492
  5. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Am Rev Respir Dis. 1988 May;137(5):1141-6 PMID: 3143278
  6. Maximum growth rate of Mycobacterium avium in continuous culture or chronically infected BALB/c mice.
    Microbios. 1987;52(211):97-103 PMID: 3695991
  7. Mycobacterium avium complex infection.
    J Infect Dis. 1988 May;157(5):863-7 PMID: 3283260
  8. Immunological approach for control of Mycobacterium avium-intracellulare infections in AIDS-an hypothesis.
    Int J Lepr Other Mycobact Dis. 1988 Sep;56(3):455-63 PMID: 3047286
  9. Role of macrophages in lipid metabolism.
    J Cardiovasc Pharmacol. 1987;10 Suppl 9:S7-10 PMID: 2447441
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1989-04-00
Pages
1332-5
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC313272
Subset
IM
Grants
PHS HHS · 1 RO1 A121919 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]